GLP-1 receptor agonists such as semaglutide (marketed as Ozempic and Wegovy) and the dual GIP/GLP-1 agonist tirzepatide (marketed as Mounjaro and Zepbound) are FDA-approved prescription medications for specific indications in diabetes management and, in some cases, chronic weight management
[PubMed ID: 26556726]
Another autophagy inhibitor 3-MA also produced rescuing effects but to a smaller extent in erastin-treated cells
Heerspink HJ, Sattar N, Pavo I, Haupt A, Duffin KL, Yang Z, et al
Suplemento en cpsulas diseado como apoyo en programas de control de peso acompaados de alimentacin equilibrada y actividad fsica
Lixisenatide and beinaglutide Lixisenatide and beinaglutide, including EX-BID as discussed earlier, are classified as short-acting GLP-1RAs based on pharmacokinetic characteristics such as clearance half-life and concentration-time distribution